Andolong, Eustace Noah R.
HRN: 25-25-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/11/2024
06/17/2024
ORAL
2.5ml
3x A Day
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes